Pennsylvania Radiation Oncologist to Receive Gold Medal Award

5/19/2004

From: Beth Bukata of the American Society for Therapeutic Radiology and Oncology 703-227-0156 or bethb@astro.org

WASHINGTON, May 19 -- The American Society of Radiology and Oncology is pleased to name Eli J. Glatstein, M.D., one of its three 2004 Gold Medal winners. Dr. Glatstein, along with Luka Milas, M.D., Ph.D., and Paul Wallner, D.O., will receive his award on Monday, October 4, during ASTRO's 46th Annual Meeting being held in Atlanta on October 3-7.

"The Gold Medal designation, the highest honor ASTRO bestows, is given in recognition of distinguished accomplishments and contributions in the field of radiation oncology," said Joel E. Tepper, M.D., ASTRO Chair. "I'm very proud of our three outstanding Gold Medalists. It is a testament to the high caliber of physicians and scientists who are members of our Society."

Dr. Glatstein, a Professor and Vice Chairman in the Department of Radiation Oncology at the University of Pennsylvania Medical Center Philadelphia, Pa., has spent more than 40 years in the field after receiving his medical degree from the Stanford University School of Medicine. During his impressive career, Dr. Glatstein significantly improved how physicians stage cancer, particularly Hodgkin's disease. While working as Chief of the Radiation Oncology Branch, Clinical Oncology Program in the Division of Cancer Treatment at the National Cancer Institute in Bethesda, Md., in the early 1970s, Dr. Glatstein transformed radiation oncology by combining it with medical oncology, thus changing the stature of radiation oncology within the general cancer community.

"I'm exceedingly pleased, proud and happy," said Dr. Glatstein. "I'm thankful to the committee for including me as one of the recipients this year."

For a photo of Dr. Glatstein, please contact Beth Bukata at 703-227-0156 or bethb@astro.org For more information on radiation therapy or ASTRO's Annual Meeting, please visit http://www.astro.org.

ASTRO is the largest radiation oncology society in the world, with more than 7,500 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment. The ASTRO Annual Meeting typically draws 9,000 healthcare professionals.